Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
The LKB1-AMPK Pathway-Friend or Foe in Cancer?
D. Grahame Hardie
Research output
:
Contribution to journal
›
Editorial
›
peer-review
68
Citations (Scopus)
Overview
Fingerprint
Projects
(2)
Fingerprint
Dive into the research topics of 'The LKB1-AMPK Pathway-Friend or Foe in Cancer?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
In Cancer
100%
Biguanides
100%
LKB1-AMPK Pathway
100%
Cancer Cells
50%
Diabetic
50%
Metformin
50%
Cancer Incidence
50%
AMPK Activator
50%
Mouse Tumor
50%
Medicine and Dentistry
Malignant Neoplasm
100%
AMP-Activated Protein Kinase
100%
Cancer Cell
25%
Neoplasm
25%
Glycon
25%
Diabetes Mellitus
25%
Biguanide
25%
Biguanide Derivative
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
33%
Metformin
33%
Diabetes Mellitus
33%
Biguanide
33%
Biguanide Derivative
33%